Gail Devers

Horizon Therapeutics plc to Highlight Data and Education on Thyroid Eye Disease (TED) at the Endocrine Society (ENDO) 2022 Annual Conference

Retrieved on: 
Thursday, June 2, 2022
Health, Diabetes, Managed Care, General Health, Clinical Trials, Pharmaceutical, Optical, ENDO, Atlantic Station, Conference, Insomnia, National Track and Field Hall of Fame, Autoantibody, 2013 British National Track Championships, Weight loss, Inflammation, Irritation, Gold, Courage, Swelling, Convention, Endocrine system, Blood, Graves' ophthalmopathy, Diagnosis, Autoimmunity, National Primate Research Exhibition Hall, American Association of Clinical Endocrinologists, Patient, Career, Communications center, Cell, Translation, Exophthalmos, Fibroblast, University, Dry, Michigan Medicine, Teprotumumab, Gail Devers, Science, Health, Education, Fatigue, Strabismus, LinkedIn, TED, NorthShore University HealthSystem, Disease, Nasdaq, Lists of World Heritage Sites, Division, Twitter, Diplopia, Cover My Eyes (Pain and Heaven), Instagram, European Group, Pharmaceutical industry, Veterinary medicine, Olympian, Endocrinology, Facebook

ET in ENDOExpo Theater 1, titled Evolution of Thyroid Eye Disease (TED) Treatment With Teprotumumab: Translating Bench to Bedside with Terry J. Smith, M.D., Michigan Medicine Eye Plastic, Facial Cosmetic & Orbital Surgery, Kellogg Eye Center, University of Michigan Medical School.

Key Points: 
  • ET in ENDOExpo Theater 1, titled Evolution of Thyroid Eye Disease (TED) Treatment With Teprotumumab: Translating Bench to Bedside with Terry J. Smith, M.D., Michigan Medicine Eye Plastic, Facial Cosmetic & Orbital Surgery, Kellogg Eye Center, University of Michigan Medical School.
  • The event, Achieving Gold in the Co-Management of Thyroid Eye Disease (TED), will be held in The Career and Communications Center in the Exhibit Hall on Saturday, June 11 at 11 a.m.
  • Gail will also be sharing her story between 11 a.m. and 4 p.m.
  • After a harrowing two-and-a-half-year quest for answers, she was diagnosed with Graves disease in 1990, just two years before winning her first Olympic gold medal.

Gail Devers, Three-Time Olympic Gold Medalist, Partners with the Graves’ Community to FOCUS on Thyroid Eye Disease

Retrieved on: 
Monday, June 28, 2021
General Health, Other Health, Health, Pharmaceutical, Optical, Thyroid disease, Anatomy, Autoimmune diseases, Organ systems, Organs anatomy), Graves' disease, Thyroid, Gail Devers, GD, Autoimmunity, Book:Thyroid, British Thyroid Foundation, Gail Devers, Graves’ Disease, Thyroid Eye Disease, The Graves’ Disease and Thyroid Foundation, Prevent Blindness, Horizon, GAIL DEVERS, GRAVES’ DISEASE, THYROID EYE DISEASE, THE GRAVES’ DISEASE AND THYROID FOUNDATION, PREVENT BLINDNESS, HORIZON

Horizon and Devers are collaborating with The American Autoimmune Related Diseases Association , the Graves Disease and Thyroid Foundation and Prevent Blindness to help people living with Graves disease FOCUS on their eye health.

Key Points: 
  • Horizon and Devers are collaborating with The American Autoimmune Related Diseases Association , the Graves Disease and Thyroid Foundation and Prevent Blindness to help people living with Graves disease FOCUS on their eye health.
  • Gail Devers is a world-renowned track star and three-time Olympic gold medalist who has been living with Graves disease and symptoms of TED for more than 30 years.
  • After a harrowing two-and-a-half-year quest for answers, she was diagnosed with Graves disease in 1990, just two years before winning her first Olympic gold medal.
  • The Graves Disease and Thyroid Foundation (GDATF) is the leading source of help and hope for people with Graves disease and other thyroid related disorders.